ORIGINAL RESEARCH article
Front. Virol.
Sec. Translational Virology
Volume 5 - 2025 | doi: 10.3389/fviro.2025.1585217
Single cell RNA transcriptome response to fentanyl use in persons with hepatitis C virus infection
Provisionally accepted- 1Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States
- 2Division of Digestive Diseases, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio, United States
- 3Miami Valley Regional Crime Laboratory / Montgomery County Coroner's Office, Dayton, United States
- 4Christ Hospital, Cincinnati, Ohio, United States
- 5Department of Psychological Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, Indiana, United States
- 6Department of Emergency Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio, United States
- 7Department of Emergency Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, United States
- 8College of Medicine, University of Cincinnati, Cincinnati, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The US has experienced a major drug epidemic in recent years, attributed in large part to synthetic opioids such as fentanyl. Here, we evaluated how recreational / non-prescribed fentanyl use in persons living with HCV infection impacted gene expression profiles in the peripheral blood. Whole blood was collected from 11 individuals, including 4 HCV-negative healthy controls, 4 HCV-positive individuals with current fentanyl use, and 3 HCV-positive individuals with no current fentanyl / no opioid use. The median HCV RNA level was 5.6 log10 copies/mL. Cell frequencies were not different by fentanyl status except for non-CD4+, non-CD8+ T cells (higher for fentanyl use; p = 0.052). When comparing HCV-positive persons with / without fentanyl detected in their blood, 106 differentially expressed genes (DEGs) were identified, including 11 in CD4+ T lymphocytes, 46 in CD8+ T lymphocytes, 5 in monocytes, 13 in B lymphocytes (excluding plasmablasts), 24 in plasmablasts, 2 in dendritic cells, and 13 in NK cells. Seven DEGs – DHRS4L2, GZMA, H1-3, HLA-C, ISG15, PARP8, PRKX – were shared across multiple cell types, with the majority being involved in host defenses against viruses. Enrichment analysis of differentially expressed genes identified genes involved in multiple cellular processes and phenotypes. Expression of the HCV entry factor CD81 was high in PBMCs; however, other HCV entry factors were expressed at low levels, and none were differentially expressed in HCV-positive persons with / without fentanyl detected in their blood. These results highlight multiple pathways by which commonly abused opioids may affect HCV pathogenesis and may reveal additional pathways for novel target-specific therapeutic interventions and enhance the clinical management of this difficult-to-treat population.
Keywords: opioid, Fentanyl, Drug use, Hepatitis C virus, HCV, single cell transcriptome
Received: 28 Feb 2025; Accepted: 29 Sep 2025.
Copyright: © 2025 Roskin, Meeds, Madhuravasal Krishnan, Juhascik, Cafardi, Brown, Freiermuth, Lyons, Sherman and Blackard. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jason Blackard, jason.blackard@uc.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.